Evidence map›Paper›PMID 37749878›Full record

ArticleGut microbes2023

Human gut microbiome and metabolite dynamics under simulated microgravity.

Ana Ramos-Nascimento, Lucia Grenga, Sven-Bastiaan Haange, Alexandra Himmelmann, Franca Sabine Arndt, Yen-Tran Ly, Guylaine Miotello, Olivier Pible, Nico Jehmlich, Beatrice Engelmann and 8 more

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Gut microbes · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Novel purine derivatives mitigate hypoxia ischemia related brain injury through agrin, zyxin and synaptotagmin proteins.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  6. [Potential biological mechanisms underlying spaceflight-induced depression symptoms in astronauts].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Ana Ramos-NascimentoInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0000-0003-2437-3445
Lucia GrengaUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols sur Cèze, France.ORCID 0000-0001-5560-1717
Sven-Bastiaan HaangeDepartment of Metabolomics, UFZ-Helmholtz Centre for Environmental Research Leipzig, Leipzig, Germany.ORCID 0000-0003-2952-1152
Alexandra HimmelmannInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0009-0003-9478-1185
Franca Sabine ArndtInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0000-0003-0977-3969
Yen-Tran LyInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0009-0007-0048-0218
Guylaine MiotelloUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols sur Cèze, France.ORCID 0000-0002-2398-1249
Olivier PibleUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols sur Cèze, France.ORCID 0000-0003-4398-6730
Nico JehmlichDepartment of Metabolomics, UFZ-Helmholtz Centre for Environmental Research Leipzig, Leipzig, Germany.ORCID 0000-0002-5638-6868
Beatrice EngelmannDepartment of Metabolomics, UFZ-Helmholtz Centre for Environmental Research Leipzig, Leipzig, Germany.ORCID 0000-0002-8807-9651
Martin von BergenDepartment of Metabolomics, UFZ-Helmholtz Centre for Environmental Research Leipzig, Leipzig, Germany.ORCID 0000-0003-2732-2977
Edwin MulderInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0000-0003-1200-5792
Petra Frings-MeuthenInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0000-0001-5291-4419
Christine Elisabeth HellwegInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0000-0002-2223-3580
Jens JordanInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0000-0003-4518-0706
Ulrike Rolle-KampczykDepartment of Metabolomics, UFZ-Helmholtz Centre for Environmental Research Leipzig, Leipzig, Germany.ORCID 0000-0002-7728-6284
Jean ArmengaudUniversité Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Bagnols sur Cèze, France.ORCID 0000-0003-1589-445X
Ralf MoellerInstitute of Aerospace Medicine, German Aerospace Center (DLR e.V.), Cologne, Germany.ORCID 0000-0002-2371-0676
Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR) · DEHelmholtz Centre for Environmental Research · DECommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Artificial Gravity Bed Rest - European Space Agency (AGBRESA) study was the first joint bed rest study by ESA, DLR, and NASA that examined the effect of simulated weightlessness on the human body and assessed the potential benefits of artificial gravity as a countermeasure in an analog of long-duration spaceflight. In this study, we investigated the impact of simulated microgravity on the gut microbiome of 12 participants during a 60-day head-down tilt bed rest at the :envihab facilities. Over 60 days of simulated microgravity resulted in a mild change in the gut microbiome, with distinct microbial patterns and pathway expression in the feces of the countermeasure group compared to the microgravity simulation-only group. Additionally, we found that the countermeasure protocols selectively increased the abundance of beneficial short-chain fatty acids in the gut, such as acetate, butyrate, and propionate. Some physiological signatures also included the modulation of taxa reported to be either beneficial or opportunistic, indicating a mild adaptation in the microbiome network balance. Our results suggest that monitoring the gut microbial catalog along with pathway clustering and metabolite profiling is an informative synergistic strategy to determine health disturbances and the outcome of countermeasure protocols for future space missions.

Indexed as

Gastrointestinal MicrobiomeSpace FlightWeightlessnessBed RestHead-Down TiltHumansAGBRESAbed rest studyfunctional analysisgut metabolitesGut microbiomemetaproteomicsmicrogravitySCFAspaceflight

Identifiers

PMID37749878
PMCPMC10524775
OpenAlexW4387033670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.